Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Author:
Affiliation:
1. Bone Marrow Transplantation Center, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People’s Republic of China
2. Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, People’s Republic of China
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2775640/wu_2021_oi_201052_1611112258.61091.pdf
Reference22 articles.
1. An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.;Martin;Blood,2017
2. Current issues in chronic graft-versus-host disease.;Socié;Blood,2014
3. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.;Wolff;Biol Blood Marrow Transplant,2010
4. Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease.;Wolff;Biol Blood Marrow Transplant,2011
5. Acute graft-versus-host disease—biologic process, prevention, and therapy.;Zeiser;N Engl J Med,2017
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Updates in chronic graft-versus-host disease: novel treatments and best practices in the current era;Bone Marrow Transplantation;2024-07-31
2. The Application of Umbilical Cord Blood-derived Platelet Gel for Skin Ulcers Associated With Chronic Graft-Versus-Host Disease in Pediatrics: A Randomized Trial;Transplantation and Cellular Therapy;2024-07
3. Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis;Annals of Hematology;2024-06-25
4. Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis;New England Journal of Medicine;2024-04-25
5. ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults;European Respiratory Journal;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3